PGHL.BO
PGHL.BO
INE199A01012
PROCTER & GAMBLE HEALTH LIMITE
Loading chart...

Company Profile

Procter & Gamble Health Limited manufactures and markets pharmaceutical and chemical products in India and internationally. It offers over-the-counter products, vitamins, minerals, and supplements under the Betamil, Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen brand names. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. The company operates as a subsidiary of Procter & Gamble Overseas India B.V.

Related stocks

AARTIPHARM.NS
AARTIPHARM.NS • India
AARTI PHARMALABS LIMITED
855.5 INR
801.58M USD 1Y +2.5%
STAR.NS
STAR.NS • India
STRIDES PHARMA SCI LTD
1,085.3 INR
1.03B USD 1Y +37.4%
FDC.BO
FDC.BO • India
FDC LTD.
330.1 INR
555.32M USD 1Y -27.9%
NATCOPHARM.NS
NATCOPHARM.NS • India
NATCO PHARMA LTD.
789.4 INR
1.5B USD 1Y -1.7%
ASTRAZEN.BO
ASTRAZEN.BO • India
ASTRAZENECA PHARMA INDIA LTD.
5,831.85 INR
1.51B USD 1Y -38.5%
ALIVUS.NS
ALIVUS.NS • India
ALIVUS LIFE SCIENCES LTD
1,326.3 INR
1.68B USD 1Y +45.4%
APLLTD.NS
APLLTD.NS • India
ALEMBIC PHARMA LTD
800.95 INR
1.63B USD 1Y -14%
AKUMS.NS
AKUMS.NS • India
AKUMS DRUGS AND PHARMA L
751.85 INR
1.19B USD 1Y +78.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

6/7 High
5Y Volatility
23.8% p.a.
Max Drawdown (5Y)
-31.5%
Sharpe Ratio (5Y)
-0.20
Beta Factor
0.18
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (23.8% p.a.).
ende